Pinte S - Search Results

1

Differential proteomic analysis of human glioblastoma and neural stem cells reveals HDGF as a novel angiogenic secreted factor.

Thirant C, Galan-Moya EM, Dubois LG, Pinte S, Chafey P, Broussard C, Varlet P, Devaux B, Soncin F, Gavard J, Junier MP, Chneiweiss H. Thirant C, et al. Among authors: pinte s. Stem Cells. 2012 May;30(5):845-53. doi: 10.1002/stem.1062. Stem Cells. 2012. PMID: 22331796 Clinical Trial.

2

Egfl7 promotes tumor escape from immunity.

Pinte S, Soncin F. Pinte S, et al. Oncoimmunology. 2012 May 1;1(3):375-376. doi: 10.4161/onci.18964. Oncoimmunology. 2012. PMID: 22737620 Free PMC article.

3

Egfl7 promotes tumor escape from immunity by repressing endothelial cell activation.

Delfortrie S, Pinte S, Mattot V, Samson C, Villain G, Caetano B, Lauridant-Philippin G, Baranzelli MC, Bonneterre J, Trottein F, Faveeuw C, Soncin F. Delfortrie S, et al. Among authors: pinte s. Cancer Res. 2011 Dec 1;71(23):7176-86. doi: 10.1158/0008-5472.CAN-11-1301. Epub 2011 Oct 28. Cancer Res. 2011. PMID: 22037871

4

Expression of Egfl7 correlates with low-grade invasive lesions in human breast cancer.

Philippin-Lauridant G, Baranzelli MC, Samson C, Fournier C, Pinte S, Mattot V, Bonneterre J, Soncin F. Philippin-Lauridant G, et al. Among authors: pinte s. Int J Oncol. 2013 Apr;42(4):1367-75. doi: 10.3892/ijo.2013.1820. Epub 2013 Feb 8. Int J Oncol. 2013. PMID: 23404186

5

Endothelial Cell Activation Is Regulated by Epidermal Growth Factor-like Domain 7 (Egfl7) during Inflammation.

Pinte S, Caetano B, Le Bras A, Havet C, Villain G, Dernayka R, Duez C, Mattot V, Soncin F. Pinte S, et al. J Biol Chem. 2016 Nov 11;291(46):24017-24028. doi: 10.1074/jbc.M116.731331. Epub 2016 Sep 20. J Biol Chem. 2016. PMID: 27650497 Free PMC article.

6

EGF repeats of epidermal growth factor‑like domain 7 promote endothelial cell activation and tumor escape from the immune system.

Pinte S, Delfortrie S, Havet C, Villain G, Mattot V, Soncin F. Pinte S, et al. Oncol Rep. 2022 Jan;47(1):8. doi: 10.3892/or.2021.8219. Epub 2021 Nov 5. Oncol Rep. 2022. PMID: 34738625

7

Scavenger chemokine (CXC motif) receptor 7 (CXCR7) is a direct target gene of HIC1 (hypermethylated in cancer 1).

Van Rechem C, Rood BR, Touka M, Pinte S, Jenal M, Guérardel C, Ramsey K, Monté D, Bégue A, Tschan MP, Stephan DA, Leprince D. Van Rechem C, et al. Among authors: pinte s. J Biol Chem. 2009 Jul 31;284(31):20927-35. doi: 10.1074/jbc.M109.022350. Epub 2009 Jun 12. J Biol Chem. 2009. PMID: 19525223 Free PMC article.

8

The receptor tyrosine kinase EphA2 is a direct target gene of hypermethylated in cancer 1 (HIC1).

Foveau B, Boulay G, Pinte S, Van Rechem C, Rood BR, Leprince D. Foveau B, et al. Among authors: pinte s. J Biol Chem. 2012 Feb 17;287(8):5366-78. doi: 10.1074/jbc.M111.329466. Epub 2011 Dec 19. J Biol Chem. 2012. PMID: 22184117 Free PMC article.

9

Identification in the human candidate tumor suppressor gene HIC-1 of a new major alternative TATA-less promoter positively regulated by p53.

Guerardel C, Deltour S, Pinte S, Monte D, Begue A, Godwin AK, Leprince D. Guerardel C, et al. Among authors: pinte s. J Biol Chem. 2001 Feb 2;276(5):3078-89. doi: 10.1074/jbc.M008690200. Epub 2000 Nov 9. J Biol Chem. 2001. PMID: 11073960 Free article.

10

The tumor suppressor gene HIC1 (hypermethylated in cancer 1) is a sequence-specific transcriptional repressor: definition of its consensus binding sequence and analysis of its DNA binding and repressive properties.

Pinte S, Stankovic-Valentin N, Deltour S, Rood BR, Guérardel C, Leprince D. Pinte S, et al. J Biol Chem. 2004 Sep 10;279(37):38313-24. doi: 10.1074/jbc.M401610200. Epub 2004 Jul 1. J Biol Chem. 2004. PMID: 15231840 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

24 results

Search Page